Our colleague Vera Bonderovic recently sat down for an interview with Bloomberg Adria in Belgrade.
In this engaging discussion Vera sheds light on the reasons behind the rapid market growth of organ-on-chip technologies, as well as, their transformative potential in phasing out animal testing. She also highlights how these advanced technologies are already making waves in the pharmaceutical industry, revolutionizing the way we approach drug development.
Watch the full interview here